BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Pharmacogenetics
,
Prozac
,
rs2230926
,
FABP1
,
Fatty acid metabolic process
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1,4-dioxane
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
Ugt2b37
Obp3
CYP4A22
Rup2
BCL6
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
MCLACHLAN_DENTAL_CARIES_UP
MODULE_84
UEDA_PERIFERAL_CLOCK
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Genotoxic and non-genotoxic carcinogens effects on liver gene expression
Fetal murine thymocytes stiumlated with TCDD or dioxane
Explore Curated Studies Results
Literature
Most Relevant Literature
Influence of dioxane on the hydration shell of polypeptides].
The impact of chlorinated solvent co-contaminants on the biodegradation kinetics of 1,4-dioxane.
Modeling of phase separation mechanism in polycaprolactone/dioxane binary systems.
Amphiphile behavior in mixed solvent media I: self-aggregation and ion association of sodium dodecyl…
Biodegradation of 1,4-dioxane by a Flavobacterium.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Te…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ